UBS Group’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.5K | Buy |
|
|||||
|
2025
Q1 | $76.1K | Buy |
|
|||||
|
2024
Q4 | $104K | Buy |
|
|||||
|
2024
Q3 | $9.84K | Sell |
|
|||||
|
2024
Q2 | $61.9K | Sell |
|
|||||
|
2024
Q1 | $238K | Buy |
|
|||||
|
2023
Q4 | $71.8K | Buy |
|
|||||
|
2023
Q3 | $599 | Sell |
|
|||||
|
2023
Q2 | $277K | Buy |
|
|||||
|
2023
Q1 | $458K | Sell |
|
|||||
|
2022
Q4 | $3.13M | Buy |
|
|||||
|
2022
Q3 | $541K | Sell |
|
|||||
|
2022
Q2 | $900K | Sell |
|
|||||
|
2022
Q1 | $3.22M | Buy |
|
|||||
|
2021
Q4 | $3.44M | Sell |
|
|||||
|
2021
Q3 | $3.13M | Buy |
|
|||||
|
2021
Q2 | $960K | Sell |
|
|||||
|
2021
Q1 | $3.16M | Buy |
|
|||||
|
2020
Q4 | $96K | Buy |
|
|||||
|
2020
Q3 | $94K | Sell |
|
|||||
|
2020
Q2 | $4.15M | Sell |
|
|||||
|
2020
Q1 | $6.43M | Buy |
|
|||||
|
2019
Q4 | $6.95M | Buy |
|
|||||
|
2019
Q3 | $4.84M | Buy |
|
|||||
|
2019
Q2 | $2.88M | Sell |
|
|||||
|
2019
Q1 | $4.31M | Sell |
|
|||||
|
2018
Q4 | $6.87M | Buy |
|
|||||
|
2018
Q3 | $2.09M | Buy |
|
|||||
|
2018
Q2 | $2.09M | Sell |
|
|||||
|
2018
Q1 | $7.9M | Buy |
|
|||||
|
2017
Q4 | $132K | Sell |
|
|||||
|
2017
Q3 | $2.08M | Buy |
|
|||||
|
2017
Q2 | $33K | Sell |
|
|||||
|
2017
Q1 | $28K | Sell |
|
|||||
|
2016
Q4 | $435K | Buy |
|
|||||
|
2016
Q3 | $14K | Sell |
|
|||||
|
2016
Q2 | $863K | Buy |
|
|||||
|
2016
Q1 | $41K | Sell |
|
|||||
|
2015
Q4 | $937K | Buy |
|
|||||
|
2015
Q3 | $148K | Buy |
|
|||||
|
2015
Q2 | $121K | Buy |
|
|||||
|
2015
Q1 | $48K | Sell |
|
|||||
|
2014
Q4 | $42K | Buy |
|